Olaparib 150 mg Tablets are prescription targeted anticancer medicines used to treat certain cancers, including ovarian, breast, pancreatic, and prostate cancer in eligible patien…
Olaparib 150 mg Tablets are prescription targeted anticancer medicines used to treat certain cancers, including ovarian, breast, pancreatic, and prostate cancer in eligible patients. Olaparib belongs to the poly (ADP-ribose) polymerase (PARP) inhibitor class and works by blocking enzymes involved in DNA repair, helping prevent cancer cells from surviving and multiplying.
Olaparib 150 mg Tablets are oral targeted anticancer medicines belonging to the PARP inhibitor class. They inhibit PARP enzymes, which play an important role in repairing damaged DNA. By blocking these enzymes, olaparib can cause DNA damage to accumulate in cancer cells, particularly those with certain DNA repair deficiencies, such as BRCA1 or BRCA2 mutations.
Olaparib is used for specific indications involving ovarian, breast, pancreatic, and prostate cancers, depending on the patient's clinical condition, biomarker status, previous treatment, and approved treatment guidelines. It may be prescribed alone or as maintenance therapy following other cancer treatments. Treatment should be initiated and monitored by an oncologist, with regular blood counts and other appropriate laboratory assessments.
Olaparib — 150 mg per tablet.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
